PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
- 4 February 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 20 (5), 585-597
- https://doi.org/10.1016/s1473-3099(19)30739-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Template protocol for clinical trials investigating vaccines—Focus on safety elementsVaccine, 2013
- A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian ChildrenPLOS ONE, 2012
- The NTS-DBL2X Region of VAR2CSA Induces Cross-Reactive Antibodies That Inhibit Adhesion of Several Plasmodium falciparum Isolates to Chondroitin Sulfate AThe Journal of Infectious Diseases, 2011
- Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite IsolatesPLOS ONE, 2011
- Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSAProceedings of the National Academy of Sciences of the United States of America, 2010
- Placental Malaria Induces Variant-Specific Antibodies of the Cytophilic Subtypes Immunoglobulin G1 (IgG1) and IgG3 That Correlate with Adhesion Inhibitory ActivityInfection and Immunity, 2005
- Effects of Pregnancy and Intensity of Plasmodium falciparum Transmission on Immunoglobulin G Subclass Responses to Variant Surface AntigensInfection and Immunity, 2005
- Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malariaMolecular Microbiology, 2003
- The pathogenic basis of malariaNature, 2002
- Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human PlacentaScience, 1996